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Background
• PCOS is characterized by hyperandrogenism and menstrual
irregularity in adolescents. Prevalence of depression and
anxiety is increased in PCOS.1
• Treatment entails healthy lifestyle changes in conjunction with
medications such as the insulin sensitizer metformin, oral
contraceptives, and antiandrogens.2
• The PCOS Clinic at Children’s Mercy is led by a multidisciplinary
team that provides medical care, dietary and lifestyle
counseling, and mental health evaluation to adolescent girls
• Anecdotally, patients were not following their prescribed
treatment regimen at follow-up.
• Objective: examine medication non-adherence and evaluate
demographics and health differences between prescription
adherent and non-adherent individuals.

Methods

Results
Table 1. Distribution of Caucasians and Non-Caucasians in medication adherent and
non-adherent to pharmacologic treatment groups.

Caucasian (n=35)
Hispanic
NonHispanic
Unknown
Non-Caucasian
(n=9)
Hispanic
NonHispanic
Unknown

Adherent
22 (63%)
7

Non-Adherent
13 (37%)
6

15
0

6
1

4 (44%)
1

5 (55%)
0

2
1

5
0

• Table 1 highlights 18 of 44 girls (41%) failed to comply with their prescribed
Reason for Non-Adherence # Complaints
metformin and/or oral contraceptive regimes at first follow-up.
GI side effects
8
• The majority of patients were Caucasian (35/44, 70%) and were more likely to
be adherent (63%) vs. non-adherent (37%). Of the adherent Caucasians, 68%
Did not refill
3
were non-Hispanic and 32% were Hispanic. Data revealed that all nonDid not feel like medications
adherent patients were African American.
helped
3
• No effect of insurance type (Table 2) or history of GI issues (Table 3) on
adherence was seen.
Reluctant parents
3
Table 3. Prevalence of concurrent psychiatric disorder or GI issues amongst patients in
treatment adherent and non-adherent groups at diagnostic visit.

Table 2. Race, ethnicity, and type of insurance coverage of PCOS patients included in
secondary data analysis.

Race and Ethnicity
Insurance Coverage
• A secondary data analysis (n=50) was conducted on patients 13-18
years old diagnosed with PCOS between August 1, 2015 and
Private Public Unknown
December 31, 2020. Six were omitted due to lack of information
Caucasian, Hispanic (n=13)
2
10
1
on medication adherence (n=44).
Caucasian, Non-Hispanic (n=21)
15
6
0
• All subjects presented with signs of biochemical/clinical
hyperandrogenism and irregular menses. Patients were divided
Caucasian, Unknown (n=1)
1
0
0
into adherent and non-adherent groups based on provider
documentation.
• Factors considered included race, ethnicity, medical history
(psychiatric disorders [depression, anxiety], attention deficit
African American, Non-Hispanic (n=6)
3
3
0
hyperactivity disorder [ADHD], and gastrointestinal [GI] issues),
and insurance coverage.
African American, Unknown (n=1)
0
1
0
• Reasons for non-adherence across individuals were also noted.
Asian, Non-Hispanic (n=1)

1

0

0

American Indian/Alaskan Native,
Non-Hispanic (n=1)

0

1

0

Forgot to take medication
Does not compliment
Past Medical History
lifestyle
Depression, Anxiety, or ADHD
GI Issue
Does not like taking pills
Adherent (n=26)
8 (31%)
3 (12%)
Metformin recall
Non-Adherent (n=18)
7 (39%)
0 (0%)
Does not like getting periods
• Of the non-adherent group, 39% had a previously diagnosed psychiatric
Began other medications
disorder or ADHD, in contrast to the 31% of the adherent group (Table 3).
• Further review of the non-adherent patients who attributed non-adherence to
Rely on contraceptives
GI side effects (Table 4) revealed all were taking metformin and lacked baseline
No comment
GI concerns. 5/8 (63%) had a past medical history of anxiety or depression.
• None of the girls who voiced one of the other top 4 most popular reasons
(Table 4) for non-adherence had a psychiatric history.

2
2
1
1
1
1
1

Table 4. List of reasons for not adhering to prescribed
medication plan provided by patients.
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Conclusion
• Medication adherence is a barrier to treatment to adolescents with PCOS.
Non-adherence can contribute to menstrual irregularities and metabolic
consequences, thus increasing the risk for comorbidities.2
• GI upset is a known adverse effect of metformin. Interventions to improve
adherence, such as increased medication counseling regarding management
of side effects is a possible intervention. Improving adherence among
patients with a psychiatric disorder may be an additional focus point.
• Primary limitations are small group sizes and relative lack of racial diversity.
More data is needed to explore the relationship of race and adherence with
tailored interventions to remove barriers of care.
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